GENE ONLINE|News &
Opinion
Blog

2019-12-02| R&D

Regenerative Medicine provides Answer to Aging: ICare Global Health Biotech’s SRF Technology Aims to Treat Arthritis in the Elderly

by GeneOnline
Share To

The world today comprises an aging society which facing many common diseases that affect the bones, muscles and leads to deteriorated joints. Therefore, one of the major challenges for healthcare in the future is to address these issues by devising new and effective prevention methods and provide a better quality of living for the aging population.

Self Repair Factors (SRF): A New Treatment Option for Arthritis in the Elderly

Autologous platelet-rich plasma (PRP) intra-articular injection, intra-articular hyaluronic acid injection, and gluco proliferative methods are currently some of the prevalent therapies for diseases such as arthritis and muscular joint degeneration. However, they are time-consuming and have other disadvantages including lower blood platelet concentration and slower repair. Recently, ICare Global Health Biotech has launched a new product called the Self Repair Factors concentration and accelerate tissue repair. This product targets patients suffering from joint discomfort, sports injuries (sprains, strains), occupational diseases (tennis elbow, mouse shoulder, office worker shoulder, and neck stiffness and soreness, etc.), recurrent dislocation and knee pain caused by overweight.

Furthermore, this therapy integrates biomedicine, sports medicine, orthopedics, and rehabilitation treatments. After receiving the SRF injections, patients can combine it with other dynamic balance treatments to strengthen their core muscles and spinal support or relax with a deep muscle massage rehabilitation treatment to improve overall muscle and joint coordination. After the injection, the healthcare team will provide relevant suggestions for postoperative care, pay close attention to the postoperative condition, and arrange a time for a return visit to improve the maintenance of the patient’s joints.

If you wish to learn more about the platelet autogrowth factor, SRF, and peripheral blood stem cell storage products and related technologies, you may visit the Healthcare+ Expo Taiwan next week (12/5 ~ 12/8) at booth Q1413 for these two products/services.

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Discrimination Leads to Rapid Aging, Science Shows the Detrimental Effects of this Act
2024-05-17
R&D
Inside the Aging Brain: NTU Singapore’s Revelation on Memory Neuron Communication
2024-01-24
BioFuture NYC 2022: Using Technology to Prepare for an Aging Population
2022-11-22
LATEST
Eli Lilly Breaks Records with $9B Total Investment in Indiana Weight-loss Drug Expansion
2024-05-27
New Regulatory Measures in China A First in the Fight Against Sedentary Behavior in Children
2024-05-24
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024
2024-05-23
AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore
2024-05-23
Hims & Hers Health Inc. Tipping the Scales of the Weight Loss Market — and Wall Street is Loving it!
2024-05-22
GV Announces Cooperation with CICC
2024-05-22
Eli Lilly and Aktis Oncology Partner to Advance Novel Radiopharmaceuticals
2024-05-22
EVENT
Scroll to Top